Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Immuno-Oncology and Cell Therapy
Executive Perspectives
Targeting Tumor Recurrence to Improve Long-Term Survival for Patients
Dr Erik Manting, CEO at Mendus, is leading the development of therapeutics focused on preventing the recurrence of tumors, leveraging adaptive immunity to do so.
Danny McCarthy
Dec 18, 2025 12:00am
Overcoming ADC Challenges of Toxicity and Drug Resistance with a Granzyme B Payload
Dec 4, 2025 12:00am
Report: Cancer Research Institute's 2025 Cancer Immunotherapy Insights and Impact
Dec 1, 2025 12:00am
IO360º Convenes Technology and Solution Providers to Address Key Capabilities to Advance IO Drug Development
Nov 19, 2025 12:00am
Could In Vivo CAR-T Cell Therapy Replace Ex Vivo?
Nov 17, 2025 12:00am
Shining a Light on the Immune System to Inform Medicine Development at GSK
Oct 27, 2025 1:00am
